SCHEMBL18860221

SCHEMBL18860221

CNC1CC12CCNCC2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9566394 0.88 — —
Hydrochloric Acid SCHEMBL9566429 0.86 — —
SCHEMBL24703593 0.80 KDM4E (0.32) KDM4EKMT2A
SCHEMBL25646843 0.76 KDM4E (0.31) KDM4EKMT2A
SCHEMBL23970171 0.75 KDM1A (0.32) —
SCHEMBL25646842 0.73 — —
SCHEMBL15653706 0.71 EPHX1 (0.34) KDM4EKMT2A
Hydrochloric Acid SCHEMBL23358290 0.70 ADH1B (0.30) —
SCHEMBL8222036 0.69 — —
SCHEMBL16984325 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604281-A1 2(1H)-QUINOLINONE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2020-02-05 — — EP disclosed
WO-2017083867-A1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES AFASCI, INC. (US) 2017-05-18 — — WO disclosed
Send feedback